Stock Screener App

無料 - Play StoreApp Store

インストールインストール

Dow:

Nasdaq:

S&P 500:

BRVE

$21.511.51%0.32

Braveheart Bio, Inc. Common Stock (BRVE)

Date: O: H: L: C: Vol:

Braveheart Bio, Inc. Common Stock (BRVE) 最新ニュース

Braveheart Bio, Inc. Common Stock (NASDAQ: BRVE) Stock Price, News & Analysis - Kalkine

Braveheart Bio, Inc. (NASDAQ:BRVE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Braveheart Bio, Inc. Common Stock (NASDAQ: BRVE) Stock Price, News & Analysis - kalkine.ca

OrbiMed's stake in Braveheart Bio (BRVE) falls without selling shares - Stock Titan

Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times

AH Bio Fund IV Discloses Investment at Braveheart Bio with 11.4% Stake - TradingView

Braveheart Bio CFO Acquires 27,777 Shares for $500,000. Is This a Signal BRVE IPO Is a Success? - The Motley Fool

Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors? - The Motley Fool

Braveheart Bio CEO Travis Murdoch Buys 83,333 Shares for $1.5 Million. Is This a Buy Signal for Investors? - The Motley Fool

Braveheart Bio, Inc. Common Stock (BRVE) Stock Price Today: $27.43 - Gotrade

Braveheart Bio Announces Closing of Upsized Initial Public - GlobeNewswire

Braveheart Bio raises $439.9M in upsized Nasdaq IPO - Investing.com

Braveheart Bio closes $439.9 million IPO on Nasdaq - Investing.com

Braveheart Bio Insider Bought Shares Worth $499,986, According to a Recent SEC Filing - Yahoo Finance

Braveheart Bio closes $439.9 million IPO on Nasdaq By Investing.com - Investing.com UK

Heart drug developer Braveheart Bio surges on public debut after upsized IPO - Seeking Alpha

Braveheart Bio Announces Pricing of Upsized Initial Public Offering - The Manila Times

Braveheart Bio Shares Rise After Market Debut - Yahoo Finance

Braveheart Bio Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Braveheart Bio shares surge 68% in New York trading debut - Investing.com

Braveheart Bio Jumps 68%, Capping $382.5M Nasdaq IPO - Briefs Finance

Braveheart Bio prices IPO at $18 per share, raises $382.5M - Investing.com Nigeria

Braveheart Bio, Inc. (BRVE) Company Information - Simply Wall Street

Braveheart Bio, Inc. (BRVE) stock price, news, quote and history - Yahoo Finance UK

Braveheart Bio (Nasdaq:BRVE) - Stock Analysis - Simply Wall Street

Braveheart Bio, Inc. (BRVE) Stock Price, News, Quote & History - Yahoo! Finance Canada

Braveheart Bio Expects Nasdaq Debut Aug. 6 After $18 IPO - Stock Titan

Braveheart Bio prices IPO at $18 per share, raises $382.5M - Investing.com

Cardiac drug developer Braveheart banks more than $382M in IPO - BioPharma Dive

Upcoming & Recent IPO's - IPOs Calendar - Yahoo Finance

Braveheart Bio, Inc. IPO Analysis: Financial Outlook, Broker Coverage and Listing Prospects - Minichart

Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s - Pharmaceutical Executive

Braveheart Bio Readies $300 Million IPO Plan (BRVE) - Seeking Alpha

Braveheart Bio, Attovia seek $275M and $182M in U.S. IPOs - Seeking Alpha

Braveheart Bio seeks $318.8M in IPO for heart drug - Investing.com

Braveheart Bio Files Nasdaq IPO for HCM Drug - AllSci

BRVEに類似

TRVI$13.561.81%

ABSI$11.138.02%

SRPT$18.623.17%

MESO$15.163.25%